Among 1,018 women in Kinshasa, abnormal cervical cells (LSIL or worse) were found in 31% of women living with HIV and about 4% of the others, and HPV16 was not the commonest type.
Published as "Prevalence and risk factors for cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of the Congo: a cross-sectional study". Between 2006 and 2013, four groups of women were recruited in HIV screening centres, large hospitals and primary health centres in Kinshasa; Pap smears were read by the Bethesda classification and HPV types identified in abnormal samples.
In this study women living with HIV in Kinshasa had abnormal cervical cells about eight times as often as the other groups, and HPV16 was not the commonest type found, which matters for which vaccine protects best.
Shares Centre National de Lutte contre le Cancer (CNLC), Democratic Republic of the Congo, Cervical cancer.
Shares Centre National de Lutte contre le Cancer (CNLC), Democratic Republic of the Congo, Cervical cancer.
Shares Centre National de Lutte contre le Cancer (CNLC), Democratic Republic of the Congo, Cervical cancer.
Shares Centre National de Lutte contre le Cancer (CNLC), Democratic Republic of the Congo, Cervical cancer.
Shares Centre National de Lutte contre le Cancer (CNLC), Democratic Republic of the Congo, Cervical cancer.
Shares Centre National de Lutte contre le Cancer (CNLC), Democratic Republic of the Congo, Cervical cancer.
Shares Centre National de Lutte contre le Cancer (CNLC), Democratic Republic of the Congo, Cervical cancer.
Shares Centre National de Lutte contre le Cancer (CNLC), Democratic Republic of the Congo, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/